Benjamin Fry

Zero-shot design of drug-binding proteins via neural iterative selection−expansion

This work used its strategy, termed neural iterative selection–expansion (NISE), to design proteins that, using different folds, specifically bind to two chemically distinct small-molecule drugs, exatecan and apixaban, with success rates of 100%, respectively.